Linux NetworX Cluster Aids BioCryst in Developing Innovative Treatments for Disease

Oct 09, 2001, 01:00 ET from Linux NetworX

    SALT LAKE CITY, Oct. 9 /PRNewswire/ -- Linux NetworX, a provider of
 powerful and easy-to-manage cluster computing solutions, announced today that
 BioCryst Pharmaceuticals, Inc. (Nasdaq:   BCRX) is now using a Linux NetworX
 Evolocity(TM) cluster to aid in creating pharmaceuticals for the treatment of
 human disease and illness such as influenza and hepatitis C.
     Implementing an innovative drug discovery approach, scientists at BioCryst
 create synthetic small-molecule inhibitors, atom by atom, to bind with
 specific disease-causing proteins or targets.  By identifying the target
 protein in advance and by discovering the chemical and molecular structure of
 the protein, scientists believe it is possible to design a more optimal drug
 to interact with the protein.
     "The Evolocity system from Linux NetworX speeds the rate at which BioCryst
 scientists are able to design and develop comprehensive compound libraries and
 databases of potential targets for their drug discovery efforts," said Shane
 Hiett, director of information technology for BioCryst.  "Not only does the
 Linux NetworX cluster technology fit our needs, but the ClusterWorX(R)
 management software helps us gain control of cluster administration and ensure
 cluster health."
     The massive amount of data computation inherent in drug design typically
 requires the power of a supercomputer-class system.  Cluster technology is a
 method of linking multiple computers, or compute nodes, together to form a
 powerful, unified system.  Linux NetworX clusters can match the performance of
 traditional supercomputers for a fraction of the cost.
     BioCryst's new Evolocity cluster includes 32 Pentium III 933 MHz
 processors, with 16 GB of memory and a 10/100 Ethernet network.  Linux NetworX
 configured the cluster to handle complex computer modeling applications, such
 as X-ray crystallography and combinatorial chemistry.  BioCryst utilizes the
 Linux NetworX ClusterWorX management software and signed an on-going service
 agreement as well.
     "Linux NetworX is an excellent choice for biotechnology organizations
 demanding powerful and reliable high performance computing Linux clusters,"
 said Clark Roundy, vice president of marketing for Linux NetworX.  "We are
 pleased to see companies like BioCryst rely on our technologies to enhance
 their capabilities."
 
     BioCryst Pharmaceuticals, Inc.
     www.biocryst.com
 
     Linux NetworX
     www.linuxnetworx.com
 
     Linux is a registered trademark owned by Linus Torvalds.  All other
 products, services and companies are trademarks or registered trademarks of
 their respective owners.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X56074643
 
 

SOURCE Linux NetworX
    SALT LAKE CITY, Oct. 9 /PRNewswire/ -- Linux NetworX, a provider of
 powerful and easy-to-manage cluster computing solutions, announced today that
 BioCryst Pharmaceuticals, Inc. (Nasdaq:   BCRX) is now using a Linux NetworX
 Evolocity(TM) cluster to aid in creating pharmaceuticals for the treatment of
 human disease and illness such as influenza and hepatitis C.
     Implementing an innovative drug discovery approach, scientists at BioCryst
 create synthetic small-molecule inhibitors, atom by atom, to bind with
 specific disease-causing proteins or targets.  By identifying the target
 protein in advance and by discovering the chemical and molecular structure of
 the protein, scientists believe it is possible to design a more optimal drug
 to interact with the protein.
     "The Evolocity system from Linux NetworX speeds the rate at which BioCryst
 scientists are able to design and develop comprehensive compound libraries and
 databases of potential targets for their drug discovery efforts," said Shane
 Hiett, director of information technology for BioCryst.  "Not only does the
 Linux NetworX cluster technology fit our needs, but the ClusterWorX(R)
 management software helps us gain control of cluster administration and ensure
 cluster health."
     The massive amount of data computation inherent in drug design typically
 requires the power of a supercomputer-class system.  Cluster technology is a
 method of linking multiple computers, or compute nodes, together to form a
 powerful, unified system.  Linux NetworX clusters can match the performance of
 traditional supercomputers for a fraction of the cost.
     BioCryst's new Evolocity cluster includes 32 Pentium III 933 MHz
 processors, with 16 GB of memory and a 10/100 Ethernet network.  Linux NetworX
 configured the cluster to handle complex computer modeling applications, such
 as X-ray crystallography and combinatorial chemistry.  BioCryst utilizes the
 Linux NetworX ClusterWorX management software and signed an on-going service
 agreement as well.
     "Linux NetworX is an excellent choice for biotechnology organizations
 demanding powerful and reliable high performance computing Linux clusters,"
 said Clark Roundy, vice president of marketing for Linux NetworX.  "We are
 pleased to see companies like BioCryst rely on our technologies to enhance
 their capabilities."
 
     BioCryst Pharmaceuticals, Inc.
     www.biocryst.com
 
     Linux NetworX
     www.linuxnetworx.com
 
     Linux is a registered trademark owned by Linus Torvalds.  All other
 products, services and companies are trademarks or registered trademarks of
 their respective owners.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X56074643
 
 SOURCE  Linux NetworX